{
    "2021-08-26": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Cheap Dividend Aristocrats to Buy Now",
                "features": {
                    "keywords": [
                        "Cheap",
                        "Dividend",
                        "Aristocrats",
                        "Buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-20",
                "original_text": "AbbVie Is Angling To Rival Biogen In Alzheimer's — But Is AbbVie Stock A Buy?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rival",
                        "Biogen",
                        "Alzheimer's",
                        "Stock",
                        "Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-10",
                "original_text": "AbbVie Receives a Positive Reimbursement Recommendation from the Canadian Agencies for Drugs and Technology in Health (CADTH) pan-Canadian Oncology Drug Review Expert Review Committee (pERC) for VENCLEXTA® (venetoclax) in Combination with azacitidine for Acute Myeloid Leukemia (AML) Patients",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Positive",
                        "Reimbursement",
                        "Recommendation",
                        "VENCLEXTA",
                        "AML",
                        "Patients"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-15",
                "original_text": "Best Dividend Stocks September 2021",
                "features": {
                    "keywords": [
                        "Best",
                        "Dividend",
                        "Stocks",
                        "September",
                        "2021"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2022-02-10",
                "original_text": "3 Pharma Stocks to Buy With Juicy Dividends",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stocks",
                        "Buy",
                        "Juicy",
                        "Dividends"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}